President Joe Biden announced that another 200 million doses of coronavirus vaccines are on the way, indicating that the country will run out of vaccines and doses by the end of August. The new administration feels that more vaccines are available, Biden said in a speech on Thursday (local time).

President Joe Biden said Tuesday that the United States will buy 200 million more doses of the COVID-19 vaccine to vaccinate the entire 300 million people U.S. population by early fall. US President Joe Biden said the country had signed contracts for an additional 100 million rounds of Pfizer’s vaccine and for another 100 million rounds of Moderna’s vaccine.

The US. Department of Health and Human Services (HHS) and the. Department of Defense (DoD) will purchase an additional 100 million doses of COVID-19 vaccine from Pfizer Inc. and Moderna Inc. to meet the demand for the vaccine in the United States. Today’s order brings the total dosage acquired by the two companies to 600 million doses, enough to vaccinate nearly 300 million people. The United States will also buy 100 million doses of the Biontech vaccine by Pfizer and 100 million doses of moderna vaccine.

The companies will deliver 300 million doses at regular intervals until the end of July 2021. We believe we can confirm the purchase of additional 100 million doses of the two FDA-approved vaccines from Pfizer and Moderna.

On Tuesday, the government informed the governors of its plans to increase the number of vaccines on their hands from 10 million doses a week to 86 million over the next three weeks. On January 26, President Joe Biden announced that he would buy 200 million more doses of two FDA-approved vaccines – 100 million doses of Pfizer Biontech vaccine and 100 million doses of Moderna – in what he called a “war-related effort to address the supply shortage that we inherited from the previous administration. The Biden administration said that over the next three weeks it would maintain at least 10 million minimum dose stocks with vaccine deliveries to states, tribes and territories expected to rise further by the end of March.

President Biden announced Thursday that his administration has completed an order for an additional 200 million doses of the COVID-19 vaccine by July 2021, in addition to the 400 million doses ordered from Pfizer in July 2020. President said Pfizer is on track to deliver its first vaccinated order this week and will distribute the first 200 million doses by the end of May. Pfizer has developed a two-shot regimen and the additional doses will vaccinate 300 million people, which is the largest share of the US population.

President Joe Biden announced Thursday that his administration has reached an agreement on an additional 200 million doses of COVID-19 vaccines, thus bringing the total US to 600 million. The president announced the latest deal as part of a plan he announced on Thursday in a speech to the National Institutes of Health two weeks ago. President Biden has signed an agreement to buy 200 million more COVID-19 vaccination doses from Pfizer and Moderna by the end of July, increasing the chances of delivering his promise that all Americans will be vaccinated by mid-summer.

President Biden says the United States agreed to purchase 200 million more doses of COVID-19 vaccine after he promised in January to increase the number of vaccines available to Americans. The government is demanding 100 million doses of Pfizer, Biontech and 100 million from Moderna to make them available for the summer this summer. President Joe Biden said Tuesday that the United States is working to purchase 200 million additional doses of a new coronavirus vaccine.

Biden Administration bought 200 million doses of COVID-19 vaccine from Pfizer and Moderna on Thursday. Days after taking office, President Joe Biden said that his administration plans to buy 200 million more doses of the life-saving drug from Biontech, Pfizer and 100 million more from Moderna, a company that makes the vaccine. The purchase represents a 50% increase in available supply in the US, bringing the total to 600 million doses.

President Biden announced during a trip to the National Institutes of Health on Thursday that the federal government will purchase additional 200 million doses of coronavirus vaccine. The purchase, which takes effect on Thursday, would represent a 50 percent increase in the total vaccine supply of the nations.

The Biden administration stepped up purchases of the coronavirus vaccine to protect 300 million Americans before the end of summer, while it sharply increased supplies to states during the next three weeks over complaints of shortages and inconsistent supplies. Biden announced the increase on Tuesday with the news that the Federal Government had purchased an additional 100 million doses of two approved coronavirus vaccines. That’s enough to deliver a vaccine that will vaccinate about 300 million people with 600 million doses by the end of July, boosting supply 50 percent in the US, the Washington Post reports.

With existing purchases, a Biden administration is expected to be able to deliver enough of the two approved coronavirus vaccines to states to vaccinate 300 million Americans.

In August, the Department of Health and Human Services announced that it had reached an agreement with Janssen and J. J. “s pharmaceutical subsidiary worth $1 billion for 100 million doses of its vaccine. The United States will pay the amount J J, with the option to buy another 200 million cans.

The deal with Janssen J & J Pharmaceuticals, a subsidiary worth roughly $1 billion, for 100 million doses of its vaccine gave the federal government the option of ordering another 200 million doses, the announcement said. The company was on course to deliver the first 100 million doses of the vaccine ordered in the United States, and that the company had been anticipating deliveries for months and would deliver 20 to 37 million doses before it was ready. However, the company production has been slower than hoped and all vaccine doses are not anticipated to be delivered in the coming weeks.

Other vaccine candidates have been approved for emergency use by the FDA and HHS and DoD have negotiated agreements with four other companies to buy additional vaccine doses to meet demand in the United States. The two agencies have entered contracts with four companies to accelerate development and production of vaccines using a variety of vaccine platforms and technologies to produce COVID-19 doses while clinical trials are ongoing.